The aim of this study is to assess the incidence and the clinical and therapeutic characteristics of reactive arthritis and to compare them with those of a historical cohort. We hypothesised that improved hygiene together with prevention and treatment of sexually transmitted infections may have decreased the incidence of reactive arthritis.
Study Type
OBSERVATIONAL
Enrollment
58
The following variables will be retrospectively assessed by medical record review using a standardised data collection form:demographics; gender, age; family or personal history of spondyloarthritis, psoriasis, uveitis, inflammatory bowel disease; clinical presentation; mono, oligo or polyarthritis, dactylitis, inflammatory joint pain, enthesopathy, axial symptoms, fever, extra-articular manifestations (conjunctivitis, anterior uveitis, circinate balanitis, skin rash); time interval between infection and musculoskeletal manifestations; causal microorganism if known, or triggering event; HLA-B27; radiographic sacroiliitis; treatments and outcomes (complete recovery at one year follow-up, relapse within 6 months after onset, or spondyloarthritis according to the ASAS criteria).
CHU de Besançon
Besançon, France
Centre Hospitalier Lyon Sud
Pierre-Bénite, France
To determine the incidence of reactive arthritis in patients hospitalised in the rheumatology department
Incidence of reactive arthritis in patients hospitalised in the rheumatology department
Time frame: December 2014
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.